Rare causes of acquired hypoparathyroidism

Hypoparathyroidism

Volumn , Issue , 2015, Pages 279-286

  Wémeau, Jean Louis ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Hypocalcemia; Hypoparathyroidism; Refractory

Indexed keywords

EID: 84948783774     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-5376-2_24     Document Type: Chapter

References (79)

1. Shoback D (2008) Clinical practice. Hypoparathyroidism. N Engl J Med 359:391-403
2. Al-Azem H, Khan AA (2012) Hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 26:517-522
3. Tisell LE, Hansson G, Lindberg S, Ragnhult I (1977) Hyperparathyroidism in persons treated with X-rays for tuberculous cervical adenitis. Cancer 40:846-854
4. Christmas TJ, Chapple CR, Noble JG et al (1988) Hyperparathyroidism after neck irradiation. Br J Surg 75:873-874
5. Colaço SM, Ming S, Reiff E (2007) Hyperparathyroidism after radioactive iodine therapy. Am J Surg 194:323-327
6. Adams PH, Chalmers TM (1965) Parathyroid function after I131 therapy for hyperthyroidism. Clin Sci 29:391-395
7. Komarovskiy K, Raghavan S (2012) Hypocalcemia following treatment with radioiodine in a child with Graves’ disease. Thyroid 22:218-222. doi: 10.1089/thy.2011.0094
8. Gorbman A (1950) Functional and structural changes consequent to high dosages of radioactive iodine. J Clin Endocrinol Metab 10:1177-1191
9. Soley MH, Foreman N (1949) Radioiodine therapy in Graves’ disease; a review. J Clin Invest 28:1367-1374
10. Sharma OP (1996) Vitamin D, calcium, and sarcoidosis. Chest 109:535-539
11. Brinkane A, Peschard S, Leroy-Terquem E et al (2001) Rare association of hypoparathyroidism and mediastinal-pulmonary sarcoidosis. Ann Med Interne (Paris) 152:63-64
12. Saeed A, Khan M, Irwin S, Fraser A (2011) Sarcoidosis presenting with severe hypocalcaemia. Ir J Med Sci 180:575-577. doi: 10.1007/s11845-009-0277-9
13. Badell A, Servitje O, Graells J et al (1998) Hypoparathyroidism and sarcoidosis. Br J Dermatol 138:915-917
14. Talat N, Diaz-Cano S, Schulte KM (2011) Inflammatory diseases of the parathyroid gland. Histopathology. doi: 10.1111/j.1365-2559.2011.04001
15. Cabezas-Agricola JM, Lado-Abeal JJ, Otero-Anton E et al (1996) Hypoparathyroidism in POEMS syndrome. Lancet 347:701-712
16. Belkhribchia MR, El Moutawakil B, Amarti Riffi A (2013) POEMS syndrome revealed unusually early with unexplained hepatic and peritoneal granulomas: to an associated malignant lymphoma? Rev Neurol (Paris). doi: 10.1016/j.neurol.2012.05.012
17. Soubrier MJ, Dubost JJ, Sauvezie BJ (1994) POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med 97:543-553
18. Thiele J, Ries P, Georgii A (1975) Special and functional pathomorphology of parathyroid glands as revealed in non-selected autopsies (589 cases). Virchows Arch A Pathol Anat Histol 12:367
19. Anderson TJ, Ewen SW (1974) Amyloid in normal and pathological parathyroid glands. J Clin Pathol 27:656-663
20. Ozdemir D, Dagdelen S, Erbas T (2010) Endocrine involvement in systemic amyloidosis. Endocr Pract 16:1056-1063. doi: 10.4158/EP10095.RA
21. Arutiunian VM, Eganian GA, Grigorian GA (1986) Structural and functional changes in the parathyroid glands in patients with periodic disease. Ter Arkh 58:123-125
22. Keven K, Oztas E, Aksoy H et al (2001) Polyglandular endocrine failure in a patient with amyloidosis secondary to familial Mediterranean fever. Am J Kidney Dis 38:E39
23. Ellis HA, Mawhinney WH (1984) Parathyroid amyloidosis. Arch Pathol Lab Med 108:689-690
24. Perimenis P, Marcelli S, Leteurtre E et al (2008) Riedel’s thyroiditis: current aspects. Presse Med 37:1015-1021
25. Hennessey JV (2011) Clinical review: Riedel’s thyroiditis: a clinical review. J Clin Endocrinol Metab 96:3031-3041. doi: 10.1210/jc.2011-0617
26. Woolner LB, Mcconahey WM, Beahrs OH (1957) Granulomatous thyroiditis (De Quervain’s thyroiditis). J Clin Endocrinol Metab 17:1202-1221
27. Marín F, Araujo R, Páramo C et al (1989) Riedel’s thyroiditis associated with hypothyroidism and hypoparathyroidism. Postgrad Med J 65:381-383
28. Nazal EM, Belmatoug N, de Roquancourt A et al (2003) Hypoparathyroidism preceding Riedel’s thyroiditis. Eur J Intern Med 14:202-204
29. Lorenz K, Gimm O, Holzhausen HJ et al (2007) Riedel’s thyroiditis: impact and strategy of a challenging surgery. Langenbecks Arch Surg 392:405-412
30. Hay ID (1985) Thyroiditis: a clinical update. Mayo Clin Proc 60:836-843
31. Best TB, Munro RE, Burwell S et al (1991) Riedel’s thyroiditis associated with Hashimoto’s thyroiditis, hypoparathyroidism, and retroperitoneal fibrosis. J Endocrinol Invest 14:767-772
32. Schwaegerle SM, Bauer TW, Esselstyn CB Jr (1988) Riedel’s thyroiditis. Am J Clin Pathol 90:715-722
33. Yasmeen T, Khan S, Patel SG et al (2002) Clinical case seminar: Riedel’s thyroiditis: report of a case complicated by spontaneous hypoparathyroidism, recurrent laryngeal nerve injury, and Horner’s syndrome. J Clin Endocrinol Metab 87:3543-3547
34. Lo JC, Loh KC, Rubin AL et al (1998) Riedel’s thyroiditis presenting with hypothyroidism and hypoparathyroidism: dramatic response to glucocorticoid and thyroxine therapy. Clin Endocrinol (Oxf) 48:815-818
35. Fatourechi MM, Hay ID, McIver B (2011) Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008. Thyroid 21:765-772. doi: 10.1089/thy.2010.0453
36. Horwitz CA, Myers WP, Foote FW Jr (1972) Secondary malignant tumors of the parathyroid glands. Report of two cases with associated hypoparathyroidism. Am J Med 52:797-808
37. Sherman LA, Pfefferbaum A, Brown EB Jr (1970) Hypoparathyroidism in a patient with longstanding iron storage disease. Ann Intern Med 73:259-261
38. Mautalen CA, Kvicala R, Perriard D et al (1978) Case report: hypoparathyroidism and iron storage disease. Treatment with 25-hydroxy-vitamin D3. Am J Med Sci 276:363-368
39. Himoto Y, Kanzaki S, Nomura H (1995) Hypothyroidism and hypoparathyroidism in an 11 year old boy with hemochromatosis secondary to aplastic anemia. Acta Paediatr Jpn 37:534-536
40. Lanes R, Muller A, Palacios A (2000) Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage. J Pediatr Endocrinol Metab 13:325-328
41. Chern JP, Lin KH (2002) Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Pediatr Hematol Oncol 24:291-293
42. Angelopoulos NG, Goula A, Rombopoulos G et al (2006) Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 24:138-145
43. Gamberini MR, De Sanctis V, Gilli G (2008) Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev 6(Suppl 1): 158-169
44. Shamshirsaz AA, Bekheirnia MR, Kamgar M (2003) Metabolic and endocrinologic complications in betathalassemia major: a multicenter study in Tehran. BMC Endocr Disord 3:4
45. Vullo C, De Sanctis V, Katz M (1990) Endocrine abnormalities in thalassemia. Ann N Y Acad Sci 612:293-310
46. Italian Working Group on Endocrine Complications in Non-endocrine Diseases (1995) Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Clin Endocrinol (Oxf) 42:581-586
47. De Sanctis V, Vullo C, Katz M, Wonke B, Hoffbrand VA, Di Palma A, Bagne B (1989) Endocrine complication in thalassemia major in advances and controversies. In: Buckner CD, Gale RP, Lucarreli G (eds) Thalassemia therapy. Alan Liss, New York, pp 77-83
48. De Sanctis V, Wonke B (1998) Growth and endocrine complications. In: Mediprint (ed) Growth and endocrine complications in thalassemia. Roma, pp 17-30
49. Jensen CE, Tuck SM, Agnew JE et al (1998) High prevalence of low bone mass in thalassaemia major. Br J Haematol 103:911-915
50. Tanimoto K, Okubo Y, Harada C et al (2008) Latent hypoparathyroidism in an osteoporotic patient with multiple endocrinopathies and secondary hemochromatosis due to multiple blood transfusions, unmasked by alendronate and glucocorticoid at adrenal crisis. Intern Med 47:515-520
51. Vantyghem MC, Dobbelaere D, Mention K et al (2012) Endocrine manifestations related to inherited metabolic diseases in adults. Orphanet J Rare Dis 7:11. doi: 10.1186/1750-1172-7-11
52. Shirota T, Shinoda T, Aizawa T (1992) Primary hypothyroidism and multiple endocrine failure in association with hemochromatosis in a long-term hemodialysis patient. Clin Nephrol 38:105-109
53. McCarthy JT, Hodgson SF, Fairbanks VF et al (1991) Clinical and histologic features of iron-related bone disease in dialysis patients. Am J Kidney Dis 17:551-561
54. Carpenter TO, Carnes DL Jr, Anast CS (1983) Hypoparathyroidism in Wilson’s disease. N Engl J Med 309:873-877
55. Okada M, Higashi K, Enomoto S et al (1998) A case of Wilson’s disease associated with hypoparathyroidism and amenorrhea. Nihon Shokakibyo Gakkai Zasshi 95:445-449
56. O’Donnell D, Myers AM (1990) Intestinal lymphangiectasia with protein losing enteropathy, toxic copper accumulation and hypoparathyroidism. Aust N Z J Med 20:167-169
57. Faggiano A, Pisani A, Milone F et al (2006) Endocrine dysfunction in patients with Fabry disease. J Clin Endocrinol Metab 91:4319-4325
58. Misery L, Gregoire M, Prieur F et al (2002) Fabry’s disease and hypoparathyroidism. Ann Med Interne (Paris) 153:283-285
59. Papadimitriou A, Hadjigeorgiou GM, Divari R (1996) The influence of Coenzyme Q10 on total serum calcium concentration in two patients with Kearns-Sayre Syndrome and hypoparathyroidism. Neuromuscul Disord 6:49-53
60. Tengan CH, Kiyomoto BH, Rocha MS (1998) Mitochondrial encephalomyopathy and hypoparathyroidism associated with a duplication and a deletion of mitochondrial deoxyribonucleic acid. J Clin Endocrinol Metab 83:125-129
61. Baruteau J, Levade T, Redonnet-Vernhet I et al (2009) Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD). J Pediatr Endocrinol Metab 22:1175-1177
62. Klein GL, Nicolai M, Langman CB et al (1997) Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J Pediatr 131:246-251
63. Rude RK, Oldham SB, Singer FR (1976) Functional hypoparathyroidism and parathyroid hormone endorgan resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 5:209-224
64. Klein GL, Langman CB, Herndon DN (2000) Persistent hypoparathyroidism following magnesium repletion in burn-injured children. Pediatr Nephrol 14:301-304
65. Murphey ED, Chattopadhyay N, Bai M et al (2000) Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia. Crit Care Med 28:3885-3890
66. Klein GL, Herndon DN (1999) The role of bone densitometry in the diagnosis and management of the severely burned patient with bone loss. J Clin Densitom 2:11-15
67. Klein GL, Wimalawansa SJ, Kulkarni G et al (2005) The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study. Osteoporos 16:631-635
68. Pieringer H, Hatzl-Griesenhofer M, Shebl O (2007) Hypocalcemic tetany in the newborn as a manifestation of unrecognized maternal primary hyperparathyroidism. Wien Klin Wochenschr 119:129-131
69. Kristoffersson A, Dahlgren S, Lithner F, Järhult J (1985) Primary hyperparathyroidism in pregnancy. Surgery 97:326-330
70. Shangold MM, Dor N, Welt SI et al (1982) Hyperparathyroidism and pregnancy: a review. Obstet Gynecol Surv 37:217-228
71. Kelly TR (1991) Primary hyperparathyroidism during pregnancy. Surgery 110:1028-1033
72. Cooper MS (2011) Disorders of calcium metabolism and parathyroid disease. Best Pract Res Clin Endocrinol Metab 25:975-983
73. Norman J, Politz D, Politz L (2009) Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol (Oxf) 71:104-109. doi: 10.1111/j.1365-2265.2008.03495.x
74. Horjus C, Groot I, Telting D (2009) Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol Metab 22:741-749
75. Jaafar R, Yun Boo N, Rasat R (2004) Neonatal seizures due to maternal primary hyperparathyroidism. J Paediatr Child Health 40:329
76. Thomas BR, Bennett JD (1995) Symptomatic hypocalcemia and hypoparathyroidism in two infants of mothers with hyperparathyroidism and familial benign hypercalcemia. J Perinatol 15:23-26
77. Cakir U, Alan S, Erdeve O et al (2013) Late neonatal hypocalcemic tetany as a manifestation of unrecognized maternal primary hyperparathyroidism. Turk J Pediatr 55:438-440
78. Pollak MR, Brown EM, Chou YH et al (1993) Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303
79. Pearce SH, Trump D, Wooding C et al (1995) Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96:2683-2692